These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 4915447)

  • 1. Preliminary clinical evaluation of glybenclamide in treatment of diabetes mellitus.
    Johnson BF; Bhatia CK; Rzeszotarski WJ; Wolff FW
    Diabetes; 1970 Aug; 19(8):579-84. PubMed ID: 4915447
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute and chronic studies using a new oral hypoglycemic agent, glyburide.
    Herrold JN; Tzagournis M; Skillman TG
    Metabolism; 1971 Apr; 20(4):414-21. PubMed ID: 4927607
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical experience with glipizide in the treatment of mostly complicated diabetes.
    Masbernard A; Giudicelli C; Massey J
    Diabetologia; 1973 Sep; ():356-63. PubMed ID: 4772981
    [No Abstract]   [Full Text] [Related]  

  • 4. Glipizide, a new sulfonylurea in the treatment of diabetes mellitus. Summary of clinical experience in 1064 cases.
    Emanueli A; Molari E; Pirola LC; Caputo G
    Arzneimittelforschung; 1972 Nov; 22(11):1881-5. PubMed ID: 4267009
    [No Abstract]   [Full Text] [Related]  

  • 5. [Our clinical experience in the treatment of diabetes mellitus with Glybenclamide].
    Marigo S; Del Nevo G; Bini PP
    Acta Diabetol Lat; 1969; 6(2):241-6. PubMed ID: 5402700
    [No Abstract]   [Full Text] [Related]  

  • 6. [Results of a clinical test on the oral antidiabetic agent glibornuride (Ro 6-4563)].
    Leubner H
    Wien Med Wochenschr; 1973 Apr; 123(17):277-82. PubMed ID: 4574026
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of chlorpropamide treatment on insulin secretion in diabetics: its relationship to the hypoglycemic effect.
    Hecht A; Gershberg H; Hulse M
    Metabolism; 1973 May; 22(5):723-33. PubMed ID: 4704717
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral sulphonylureas in the management of diabetes.
    Jackson WP
    S Afr Med J; 1971 Jan; 45(5):118-23. PubMed ID: 4925995
    [No Abstract]   [Full Text] [Related]  

  • 9. Long-term experience with sulfonylureas and placebo.
    Singer DL; Hurwitz D
    N Engl J Med; 1967 Aug; 277(9):450-6. PubMed ID: 5340346
    [No Abstract]   [Full Text] [Related]  

  • 10. Over-all therapeutic usefulness of glybenclamide, a new hypoglycemic sulfonylurea.
    Rull JA; Gonzalez-Millan H; Quibrera R; Garcia-Viveros M; Lozano-Castaneda O
    Diabetes; 1970 Apr; 19(4):264-70. PubMed ID: 4908765
    [No Abstract]   [Full Text] [Related]  

  • 11. [Clinical experiences with oral antidiabetic HB 419 (glibenclamide)].
    Schöffling K; Petzoldt R; Althoff-Zucker C; Beyer J; Retiene K; Böhle E; Kunkel W
    Arzneimittelforschung; 1969 Aug; 19(8):Suppl:1439-45. PubMed ID: 5394468
    [No Abstract]   [Full Text] [Related]  

  • 12. Diabetes mellitus: the thin maturity-onset diabetic.
    Br Med J; 1972 Sep; 3(5828):692-4. PubMed ID: 4631184
    [No Abstract]   [Full Text] [Related]  

  • 13. [Evaluation of therapy of diabetes mellitus, with special reference to the control of diabetes mellitus with oral antidiabetics].
    Kadota I
    Nihon Rinsho; 1969 Aug; 27(8):2136-50. PubMed ID: 4901777
    [No Abstract]   [Full Text] [Related]  

  • 14. Clinical trial of glybenclamide, a hypoglycaemic agent.
    Walker RL
    Med J Aust; 1970 Nov; 2(22):1015-6. PubMed ID: 4924417
    [No Abstract]   [Full Text] [Related]  

  • 15. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
    MOSS JM; DELAWTER DE; GALLAGHER EJ
    Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral treatment of diabetes mellitus.
    Chhetri MK
    J Indian Med Assoc; 1968 May; 50(10):486-8. PubMed ID: 4883853
    [No Abstract]   [Full Text] [Related]  

  • 17. The effects of long-term therapy with oral hypoglycemic agents on the oral glucose tolerance test dynamics in male chemical diabetics.
    Tan MH; Graham CA; Bradley RF; Gleason RE; Soeldner JS
    Diabetes; 1977 Jun; 26(6):561-70. PubMed ID: 324835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Blood sugar and plasma insulin levels in children following the oral administration of glybenclamide (HB 419)].
    Weber B; Hahn W
    Z Kinderheilkd; 1970; 108(1):32-40. PubMed ID: 5440469
    [No Abstract]   [Full Text] [Related]  

  • 19. [Glucagon test in diabetics: its significance and its changes after treatment with Glybenclamide].
    Adezati L; De Lorenzi F; Prando R; Fresco G; Pagliaini R; Amore R
    Acta Diabetol Lat; 1969; 6(2):247-82. PubMed ID: 5397407
    [No Abstract]   [Full Text] [Related]  

  • 20. [HB 419 (Glybenclamide) in the treatment of diabetes mellitus].
    Singh I; Srivastava MC
    Acta Diabetol Lat; 1969; 6(2):222-40. PubMed ID: 5397406
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.